108
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial

, , , , , , , , , , , , , , , , , , , , ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon, , , , , & show all
Pages 223-231 | Received 30 Nov 2023, Accepted 27 Mar 2024, Published online: 12 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.